Health Care & Life Sciences » Biotechnology | Shanghai RAAS Blood Products Co. Ltd.

Shanghai RAAS Blood Products Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
143
511
1,480
1,650
832
1,523
Depreciation, Depletion & Amortization
17
60
105
114
150
157
Other Funds
-
493
681
34
2
2,339
Funds from Operations
150
591
841
1,753
1,145
661
Changes in Working Capital
240
89
88
387
555
398
Net Operating Cash Flow
90
502
753
1,366
590
264
Capital Expenditures
130
65
145
147
154
Sale of Fixed Assets & Businesses
-
-
19
3
114
Purchase/Sale of Investments
142
140
746
937
1,547
Net Investing Cash Flow
273
257
830
1,479
1,760
Cash Dividends Paid - Total
24
58
137
138
149
Issuance/Reduction of Debt, Net
356
72
-
450
622
Net Financing Cash Flow
332
362
544
278
471
Net Change in Cash
32
1,121
468
167
700
Free Cash Flow
220
437
608
1,219
436
Deferred Taxes & Investment Tax Credit
1
5
115
27
36
311
Net Assets from Acquisitions
-
-
-
361
73
Other Sources
-
182
57
7
-
Exchange Rate Effect
1
-
1
2
1
Other Uses
1
-
14
43
100

About Shanghai RAAS Blood Products Co.

View Profile
Address
No. 2009 Wangyuan Road
Shanghai Shanghai 201401
China
Employees -
Website http://www.raas-corp.com
Updated 07/08/2019
Shanghai RAAS Blood Products Co., Ltd. engages in the production and sale of blood products. It provides testing services for blood, vaccines, diagnostic reagents, and testing equipment. Its products include human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.